Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
28 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The companys products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringers injection, lactated ringers injection, compound amino acid injection, alanyl glutamine injection, fructose injection, fructose and sodium chloride injection, compound amino acids, fat emulsion injection, vitamin c and glucose injection, vitamin c and sodium chloride injection, kang fu xin solution and lafutidine capsules.

Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes

  
Source:
Document ID
GDPH220904D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Sichuan Kelun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Sichuan Kelun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Sichuan Kelun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Sichuan Kelun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Sichuan Kelun Pharmaceutical Co., Ltd., Medical Devices Deals, 2010 to YTD 201691
Sichuan Kelun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Sichuan Kelun Pharmaceutical Co., Ltd., Pharmaceuticals &Healthcare, Deal Details1114
  Equity Offering111
    Sichuan Kelun Pharma Completes IPO For US$734 Million111
  Debt Offering121
    Sichuan Kelun Pharma Plans to Raise up to USD269.5 Million in Public Offering of Bonds121
    Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2018 For US$175 Million131
    Sichuan Kelun Pharma Completes Public Offering Of Bonds Due 2017 For US$238 Million141
    Sichuan Kelun Pharma Announces Debt Offering Of Notes Due 2017 For US$412 Million151
  Acquisition161
    Sichuan Kelun Pharma Plans to Acquire Remaining 15% Stake in Zhejiang-based pharmaceutical unit161
    Sichuan Kelun Pharma Terminates Acquisition Of Minority Stake In Lijun International Pharma172
    Sichuan Kelun Pharma Acquires 56% Stake In Chengdu Pharma Company For US$32.8 Million191
    Sichuan Kelun Pharma Acquires Guizhou Kelun Pharma, Pharmaceutical Preparations Manufacturer201
    Sichuan Kelun Pharma Completes Acquisition of 80% Stake in Guilin Dahua Pharma for USD21.9 Million211
    Sichuan Kelun To Acquire 80% Stake In Gui Lin Dahua Pharma221
    Sichuan Kelun Pharma Acquires Anyang Dazhou Pharma, Medicines Manufacturer231
    Sichuan Kelun Pharma Completes Acquisition of Guangdong Qingfa Pharma for USD22.28 Million241
Sichuan Kelun Pharmaceutical Co., Ltd. - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
  Other Locations &Subsidiaries271
Appendix281
  Methodology281
  About GlobalData281
  Contact Us281
  Disclaimer281

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sichuan-Kelun-Pharmaceutical-Co-Ltd-002422-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-19150>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Sichuan Kelun Pharmaceutical Co., Ltd. (002422) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sichuan-Kelun-Pharmaceutical-Co-Ltd-002422-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-19150>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research